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Introduction  
  

Usher  syndrome  (USH)  is  a  complex,  rare  autosomal  recessive  genetic  disorder  that  

is  presented  in  humans  and  manifests  in  its  most  common  form  as  inherited  deaf-‐blindness  
[1].  The  genetic  disorder  is  characterized  by  variable  degrees  of  sensorineural  hearing  loss  
(SNHL),  retinitis  pigmentosa  (RP),  and  in  some  cases,  vestibular  dysfunction  [2].  Usher  
syndrome  has  a  prevalence  of  about  1  in  10,000,  indicating  that  it  is  the  most  common  form  
of  combined  deaf-‐blindness  that  plagues  the  human  population  [1].  The  syndrome  presents  
as  three  clinical  types  (Usher  syndromes  type  1,  2  or  3).  Patients  are  classified  into  the  
three  types  based  on  the  diverse  clinical  symptoms  that  are  observed  by  medical  
professionals.  This  classification  is  mainly  based  on  the  severity  and  progression  of  the  
hearing  loss,  and  the  age  of  onset  for  the  retinitis  pigmentosa  [2].    
  

Usher  syndrome  was  very  first  described  in  the  year  1858  by  Albrecht  von  Gräfe,  

who  is  considered  to  be  a  pioneer  of  modern-‐day  ophthalmology.  He  reported  a  case  of  
deaf  patients  with  retinitis  pigmentosa,  whose  two  brothers  had  the  same  exact  symptoms  
[11].  A  few  years  after  that,  one  of  von  Gräfe’s  students,  Richard  Liebreich,  examined  the  
entire  population  of  Berlin  for  an  identifiable  disease  pattern  in  people  with  retinitis  
pigmentosa  and  deafness.  Through  extensive  study,  he  found  the  syndrome  to  be  recessive  
[12].  The  syndrome  was  named  after  Charles  Usher,  a  British  ophthalmologist  who  
established  the  heritability,  pathology  and  transmission  of  this  illness  in  the  year  1914  
[11].    
  

In  Usher  syndrome  type  1,  patients  diagnosed  are  defined  as  having  congenital  

severe  to  profound  sensorineural  hearing  loss  and  vestibular  areflexia.  Retinitis  
pigmentosa  has  an  onset  typically  within  the  first  decade  of  life  for  this  type  [2].  In  Usher  
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syndrome  type  3  patients,  the  known  symptoms  such  as  hearing  loss,  vestibular  
dysfunction  and  onset  of  retinitis  pigmentosa  are  progressive,  sporadic  and  variable,  
respectively  [2].  In  Usher  syndrome  type  2,  the  focus  of  this  study,  patients  display  
congenital  moderate  to  severe  sensorineural  hearing  loss.  Overall,  patients  have  normal  
vestibular  function  and  an  onset  of  retinitis  pigmentosa  within  the  second  decade  of  life  
(unlike  type  1,  which  is  within  the  first  decade  of  life)  [2,  3].  Usher  syndrome  type  2  is  the  
most  common  form  of  Usher  syndrome.  It  accounts  for  about  50%  to  65%  of  all  cases  of  
Usher  syndrome,  whereas  Usher  syndrome  type  1  accounts  for  only  10%  to  35%  of  all  
cases  [2].  Usher  syndrome  type  3  is  quite  rare,  and  accounts  for  only  2%  to  5%  of  cases  [2].  
  

Retinitis  pigmentosa  is  a  condition  where  the  photoreceptor  cells  begin  to  

degenerate,  primarily  from  the  outer  periphery  to  the  center  of  the  retina.  First,  patients  
afflicted  tend  to  experience  night  blindness  .  Then,  they  experience  a  loss  of  peripheral  
vision.  As  retinitis  pigmentosa  progresses,  the  patient’s  field  of  vision  narrows  until  only  
central  vision  remains  [4].  This  degeneration  experienced  is  generally  attributable  to  rod  
dysfunction,  though  cones  may  degenerate  later  in  the  course  of  development.  Other  
clinical  symptoms  of  retinitis  pigmentosa  may  include,  in  addition  to  those  listed  above,  
abnormal  electroretinogram  responses,  abnormal  retinal  pigmentation  including  
peripheral  bone  spicules,  arterial  narrowing,  optic-‐nerve  pallor,  and  predisposition  to  
myopia  and  posterior  subcapsular  cataracts  [11].    
Sensorineural  hearing  loss,  on  the  other  hand,  is  often  caused  by  abnormal  
development  of  hair  cells  in  the  inner  ear.  The  inner  ear  consists  of  the  cochlea  and  the  
vestibular  labyrinth.  The  former  mediates  sound  transduction,  and  the  latter  detects  
gravitational  force  and  angular  and  linear  accelerations.  Both  contain  hair  cells  which  aid  in  
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converting  mechanical  stimuli  into  afferent  nerve  signals  toward  the  brain.  These  hair  cells  
contain,  on  their  apical  surface,  a  hair  bundle  which  contains  stereocilia,  which  consists  of  
organized  actin-‐filled  projections.  The  sensorineural  hearing  loss  and  potential  balance  
defects  in  Usher  syndrome  result  from  the  alteration  of  stereocilia  [5,  11].    
  

Usher  syndrome  is  inherited  as  an  autosomal  recessive  disorder,  meaning  both  

parents  must  contribute  a  mutation  for  this  syndrome  to  appear,  and  it  must  be  on  a  
chromosome  pair  that  is  not  one  of  the  sex  chromosomes.  Currently,  there  are  12  genes  
known  to  researchers  that  are  implicated  in  causing  Usher  syndrome.  There  are  six  genes  
that,  when  mutated,  are  linked  to  Usher  syndrome  type  1.  They  are  as  follows:  MYO7A,  

USH1C,  CDH23,  PCDH15,  USH1G,  CIB2  [2].  Mutations  in  the  MYO7A  gene,  which  encodes  
myosin  VIIA  [12],  are  responsible  for  up  to  70%  of  cases  of  Usher  syndrome  type  I  [2].  
However,  despite  its  high  correlation  with  type  1,  MYO7A  mutations  are  not  correlated  
with  Usher  syndrome  type  2  at  all,  which  is  less  severe  than  type  1  [6].  Mutations  in  three  
other  genes,  USH2A,  GPR98  and  WHRN  are  known  to  cause  Usher  syndrome  type  2.  
Specifically,  mutations  in  USH2A  account  for  85%  of  Usher  syndrome  type  2  cases,  making  
it  the  most  common  mutation  for  this  type.  Mutations  in  the  GPR98  gene,  which  encodes  
for  the  G-‐protein-‐coupled  7-‐transmembrance  receptor  CLGR1  [11],  account  for  only  6%  of  
Usher  syndrome  type  2  [2].  In  the  case  of  Usher  syndrome  type  3,  CLRN1  is  the  most  
frequent  mutated  gene.  In  addition  to  the  genes  listed  above  that  are  linked  to  a  specific  
clinical  classification  of  Usher  syndrome,  there  are  two  genes  that  when  mutated,  correlate  
with  atypical  cases  of  the  syndrome  that  do  not  fit  in  the  classifications.  The  genes  are:  

CEP250  and  ARSG  [2].    
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As  mentioned  above,  the  gene  USH2A  is  most  implicated  for  Usher  syndrome  type  2.  

The  USH2A  gene  is  responsible  for  encoding  two  isoforms  of  the  protein  usherin  [7].  
Usherin  contains  laminin  EGF  motifs,  a  pentaxin  domain,  and  many  fibronectin  type  III  
motifs  [8].  This  protein  is  a  very  important  component  of  basement  membranes,  which  are  
very  thin,  sheet-‐like  structures  that  support  and  separate  cells  in  many  tissues.  Specifically,  
usherin  is  found  in  basement  membranes  in  the  inner  ear  and  in  the  retina  (which  is  a  thin  
layer  of  light-‐sensitive  tissues  at  the  back  of  the  eye).  The  functions  of  usherin  are  still  
being  studied  extensively,  but  it  is  understood  that  the  protein  has  an  essential  role  in  the  
development  and  overall  function  of  inner  ear  hair  cells  and  photoreceptors  in  the  retina  
[9].  The  gene  that  encodes  usherin,  USH2A,    has  a  total  of  72  exons,  an  overall  length  of  800  
kb  and  is  located  at  1q41,  which  is  the  long  (q)  arm  of  chromosome  1  at  position  41  [10].  
There  have  been  a  very  large  number  of  mutations  detected  in  this  gene,  all  of  which  may  
lead  to  Usher  syndrome  type  2.  One  of  the  most  common,  however,  is  c.2299delG.  It  is  
located  on  exon  13,  which  accounts  for  just  about  15%  to  45%  of  all  mutated  alleles  of  the  

USH2A  gene  [11].    
Usher  syndrome  is  of  particular  importance  to  understand  because  of  its  public  
health  impact.  Patients  with  Usher  syndrome  may  face  social  isolation  due  to  their  varying  
inabilities  to  both  hear  or  see.  Combined  deaf-‐blindness  can  have  a  substantial  impact  on  
the  health  and  educational  functioning  of  affected  children.  They  may  have  more  doctor  
visits,  more  hospital-‐days,  more  time  lost  as  school  and  an  increased  risk  of  repeating  a  
grade  in  school  [15].  Furthermore,  children  who  suffer  from  Usher  syndrome  type  2  may  
have  poorer  self-‐esteem,  more  depression  and  anxiety,  and  more  problems  with  learning  
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[16].  Therefore,  it  is  crucial  that  more  is  understood  about  this  syndrome  to  make  steps  
towards  a  future  where  there  are  preventative  measures  that  exist.    
One  of  the  first  steps  towards  this  future  would  be  to  make  a  correct,  and  early,  
diagnosis.  The  value  of  an  early  diagnosis  for  Usher  syndrome  is  undeniable.  While  there  
may  be  adverse  effects  of  knowing  the  diagnosis  early  in  a  child’s  life,  such  as  hopelessness  
or  depression,  the  benefits  may  outweigh  the  costs.  The  burden  of  Usher  syndrome  is  
greater  than  that  of  a  hearing  or  visual  handicap  by  itself  –  combined  sensory  deficit  is  very  
difficult  to  handle.  For  the  parents  of  a  child  who  has  Usher  syndrome,  this  may  be  an  
unfathomable  burden.  Since  the  retinitis  pigmentosa  does  not  present  until  the  second  
decade  of  life,  parents  may  choose  to  have  several  children  without  knowing  the  future  
disability  that  will  plague  them.  Earlier  diagnostic  measures  allow  for  informed  family  
planning  and  genetic  counseling.  Not  only  that,  but  the  nature  of  the  retinitis  pigmentosa  is  
also  dangerous.  As  discussed  above,  the  very  first  tangible  affect  a  child  may  see  is  the  
appearance  of  night  blindness.  This  is  very  dangerous  (for  example,  when  considering  
outdoor  activities  such  as  bike-‐riding  or  crossing  the  street)  and  is  a  strong  argument  for  
earlier  diagnostic  measures,  so  children  and  their  guardians  can  be  prepared.  Additionally,  
early  diagnosis  can  assist  patients  in  learning  how  to  not  rely  on  visual  cues  for  
communication.  Since  their  vision  is  lost  slowly  and  in  the  second  decade  of  life,  they  learn  
to  augment  communication  visually  when  only  their  hearing  is  affected.  Tactile  and  other  
forms  of  assisted  communication  would  be  helpful  to  learn  as  a  child,  rather  than  waiting  
until  it  is  necessary  as  a  young  adult.  The  use  of  assistive  technologies  such  as  braille,  
walking  canes  and  service  animal  interactions  are  more  easily  learned  by  younger  
individuals,  especially  with  gradual  rather  than  sudden  dependence.  Lastly,  an  early  
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diagnosis  can  help  inform  children  and  young  adults  in  their  future  careers  and  plans.  
Beginning  to  train  for  a  career  where  vision  is  necessary  would  not  be  a  well-‐informed  
decision.  Early  diagnosis  would  allow  for  greater  information  and  support  for  a  child  who  
may  not  be  aware  their  vision  will  be  lost  in  the  future  [17].    
In  order  to  make  steps  towards  an  early  diagnosis,  a  proper  differential  diagnosis  of  
the  syndrome  is  necessary.  Unfortunately,  there  are  a  multitude  of  syndromes  that  may  
exhibit  clinical  signs  which  are  similar  to  Usher  syndrome.  The  best  method  of  identifying  
Usher  syndrome  would  be  through  a  genetic  test,  but  unfortunately  research  is  not  yet  
developed  enough  to  make  this  occur.    Not  all  of  the  genes  discovered  and  mentioned  
above  are  directly  responsible  for  every  case  of  Usher  syndrome.  Unfortunately,  there  are  
still  cases  where  the  genetic  cause  is  undeterminable.  Furthermore,  there  is  no  current  
treatment  available  for  Usher  syndrome.  The  sensorineural  hearing  loss  problem  is  
supplemented  with  the  use  of  hearing  aids  and  cochlear  implantation.  Unfortunately,  the  
retinitis  pigmentosa  has  been  unsolved  as  of  yet.  There  are  currently  no  therapeutic  
strategies  to  treat  retinal  degeneration  [11].  In  order  to  continue  to  develop  therapeutic  
strategies  for  those  afflicted,  animal  models  must  be  used  to  uncover  as  much  information  
as  possible.  Once  the  syndrome  is  even  more  understood,  the  scientific  community  can  
begin  to  develop  treatments  for  those  afflicted.  
It  is  understood  currently  that  Usher  syndrome  carriers  do  not  exhibit  any  of  the  
characteristics  of  the  diagnosable  syndrome,  such  as  variable  hearing  loss,  retinitis  
pigmentosa  and  potential  balance  defects.  Heterozygotes  are  classified  as  asymptomatic,  
and  thought  to  not  be  at  risk  of  developing  the  disorder  [13].  However,  this  idea  is  being  
questioned  and  studied  further  by  a  select  few  researchers.  Carriers  may  in  fact  exhibit  
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subtle  differences  that  have  been  mostly  undetected  thus  far.  A  groundbreaking  study  
reported  some  differences  between  10  obligate  carriers  of  Usher  syndrome  type  2  within  5  
different  families  [14].  It  was  found  that  the  carriers  of  the  gene  did  exhibit  sensorineural  
hearing  loss  at  all  frequencies,  which  was  in  excess  of  what  was  expected  for  their  age.  
However,  only  an  excess  of  10  dB  (on  average)  in  hearing  loss  at  the  frequencies  0.25  –  0.5  
kHz)  proved  to  be  significant.  When  the  carriers  were  tested  for  speech  discrimination  
scores,  they  were  all  within  the  hearing  thresholds.  There  were  a  few  other  tests  run  that  
also  found  a  general  normality  between  the  carriers  and  non-‐carriers.  The  researchers  did  
discover  a  few  vestibular  abnormalities  in  a  minority  of  the  carrier  sample,  but  it  was  not  
significant.  A  closer  look  at  ophthalmologic  findings  were  normal,  though  there  were  
subnormal  electrooculographies  in  ½  of  the  sample  group  [14].  In  another  study,  
researchers  studied  specific  language  impairment  (SLI),  which  is  a  developmental  disorder  
that  affects  an  individual’s  spoken  and/or  receptive  language  acquisition  in  the  absence  of  
neurological  deficits  [22].  They  looked  specifically  at  copy  number  variants  (CNVs),  which  
are  rare  variants  and  epigenetic  modifications,  that  may  indicate  the  level  of  burden.  It  was  
found  that  children  with  SLI  and  their  first-‐degree  relatives  have  an  increased  burden  of  
moderate-‐sized  CNVs  than  population  controls,  and  that  the  burden  and  size  of  CNVs  did  
correlate  with  the  severity  of  the  disorder.  Therefore,  carriers  of  SLI  did  exhibit  language  
problems  as  compared  to  the  population  controls  [22].  Since  these  two  studies,  no  
researchers  have  looked  at  significantly  whether  or  not  carriers  suffer  from  the  
characteristics  of  Usher  syndrome  in  any  way,  though  this  evidence  does  suggest  that  they  
may  exhibit  deficits.  This  is  the  first  focus  of  this  study.  
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Deafness  in  infancy  and  childhood  is  well  known  to  interfere  with  the  normal  
development  of  speech  and  language  [19].  Those  diagnosed  with  Usher  syndrome  type  2  
have  moderate  to  severe  hearing  loss,  but  not  congenital  profound  hearing  loss.  Therefore,  
their  ability  to  develop  speech,  while  more  impacted  than  a  person  with  no  hearing  loss,  is  
less  impacted  than  a  patient  with  fully  penetrant  Usher  syndrome  type  2.  This  is  the  second  
focus  of  this  study.  Understanding  if  the  USH2A  gene  affects  vocal  production  in  any  
tangible  way  is  an  important  factor  to  consider,  and  whether  or  not  carriers  have  any  
identifiable  and  significant  difference  in  vocal  production.  Moreover,  the  carriers  may  have  
a  different,  rather  than  comparable  but  quantitatively  reduced,  sensory  profile.    
For  this  study,  the  use  of  a  mouse  model  was  necessary.  Mouse  models  carrying  a  
mutation  in  the  USH2A  gene  have  been  identified  and  generated  in  order  to  unravel  the  
mechanisms  underlying  the  Usher  syndrome  type  2  phenotype.  When  the  USH2A  gene  is  
targeted  for  disruption  in  mice,  they  exhibit  similar  symptoms  to  humans.  They  show  a  
moderate  but  non-‐progressive  hearing  impairment,  as  well  as  progressive  photoreceptor  
degeneration,  mimicking  the  visual  and  hearing  deficits  in  Usher  syndrome  type  2  patients  
[18].  In  parallel,  the  use  of  mouse  ultrasonic  vocalizations  has  become  more  prevalent  in  
research.  They  are  often  used  as  a  testing  measure  to  observe  and  extrapolate  vocal  
communication  defects.  Wild-‐type  male  mice  have  been  recorded  and  known  to  produce  
very  abundant  vocal  signaling  in  the  ultrasonic  range.  In  the  presence  of  an  oestrus  female,  
or  female  pheromones,  adult  males  will  emit  a  large  number  of  ultrasonic  vocalizations.  In  
this  paper,  an  examination  of  the  total  time  spent  vocalizing,  and  the  shape  of  the  individual  
vocalization  calls,  were  both  used  to  help  determine  if  there  are  any  notable  differences  in  
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vocal  production  for  mice  either  carrying  a  homozygous  mutation  of  the  mouse  homolog  
(usher2a),  heterozygous  mice  (“carriers”),  or  controls.    
  

Methods  
Mouse  Breeding  
For  this  study,  USH2A  knock-‐out  male  and  female  mice  were  obtained  by  MTA  from  
Johns  Hopkins  University.  The  original  USH2A  knock-‐out  mice  were  generated  using  
methods  described  by  Liu  et  al.,  2007  [18].  At  the  University  of  Connecticut,  the  USH2A  
knock-‐out  mice  were  bred  with  wild  type  mice  (strain:  129s4/SvJae),  generating  a  group  of  
male  and  female  USH2A  heterozygous  (Het)  mice  as  the  resulting  litters.  Heterozygous  
breeding  pairs  were  re-‐derived  on  a  129s4/SvJae  background  at  the  Gene  Targeting  and  
Transgenic  Facility  (GTTF)  at  UConn  Health  Services.  The  testing  mice  were  then  generated  
by  performing  Het  x  Het  breeding.  This  allowed  for  the  subjects  to  have  a  genotype  ratio  
and  breakdown  of  1:2:1,  meaning  25%  wild-‐type  (WT),  50%  Het  and  25%  knock-‐out  (KO).  
Offspring  were  genotyped  by  PCR,  and  chosen  by  their  genotype.  This  was  done  by  
punching  their  ears,  and  then  running  a  PCR  on  the  DNA  of  the  ear  punch  using  Common  
(GTGAATACAGGCACCTCTGAATGTGAC),  Wild-‐type  Reverse  (GTCACGGCTGAATCCCGAAGC)  
and  Mutant  Reverse  (GAGATCAGCAGCCTCTGTTCCAC).    
There  was  a  total  of  36  male  mice  subjects,  although  one  of  them  (number  32)  died  
during  the  experimental  process.  Of  the  35  male  mice  whose  data  was  collected  and  
analyzed,  12  were  WT’s,  12  were  Het’s  and  the  last  11  were  KO’s.  After  the  mice  were  
weaned,  they  were  housed  separately  because  of  inter-‐male  aggression  in  single  standard  
cages  with  ample  food  and  water.  All  procedures  were  conducted  in  compliance  with  the  
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National  Institutes  of  Health  and  approved  by  the  University  of  Connecticut’s  Institutional  
Animal  Care  and  Use  Committee  (IACUC).  The  data  collectors  were  blind  to  the  genotype  of  
the  tested  animals  during  the  experimental  process.  The  data  analyzer  was  also  blind  to  the  
genotype  of  the  subjects  during  the  analysis  –  they  only  had  the  subject  number  of  the  
animals  when  analyzing  audio  files.    
  

Behavioral  Procedure  
  

The  ultrasonic  mouse  vocalizations  were  recorded  by  an  ultrasonic  microphone  (B  

&  K).  The  vocalizations  of  the  male  mice  were  recorded  when  they  were  in  the  presence  of  
a  female  mouse  in  oestrus.  To  begin,  bedding	
  from	
  one	
  of	
  two	
  female	
  mice	
  was	
  spread	
  
along	
  the	
  bottom	
  of	
  a	
  clean	
  cage.	
  This	
  was	
  to	
  ensure	
  the	
  male	
  mouse	
  was	
  inundated	
  with	
  
the	
  scent	
  of	
  the	
  female.	
  Then,	
  the	
  subject	
  was	
  placed	
  in	
  the	
  cage.	
  After	
  a	
  few	
  moments	
  of	
  
habituation,	
  one	
  of	
  the	
  two	
  unfamiliar	
  female	
  mice	
  in	
  oestrous	
  was	
  introduced	
  to	
  the	
  
subject.	
  The	
  next	
  5	
  minutes	
  of	
  interactions	
  were	
  recorded	
  by	
  the	
  microphone.	
  In	
  the	
  case	
  of	
  
this	
  experimental	
  paradigm,	
  the	
  female	
  mice	
  are	
  expected	
  to	
  vocalize	
  very	
  minimally.	
  
Therefore,	
  it	
  is	
  assumed	
  that	
  the	
  vocalizations	
  recorded	
  are	
  only	
  from	
  the	
  males	
  [20].	
  
These	
  vocalizations	
  were	
  later	
  examined	
  for	
  the	
  total	
  time	
  spent	
  vocalizing,	
  as	
  well	
  as	
  
analysis	
  of	
  the	
  shapes	
  of	
  the	
  vocalizations	
  themselves.	
  The	
  shapes	
  were	
  identified	
  
according	
  to	
  a	
  previous	
  study,	
  using	
  the	
  guide	
  in	
  Figure	
  1	
  [21].	
  	
  	
  
	
  
Data	
  Analysis	
  Procedure	
  
	
  

Once	
  the	
  audio	
  recordings	
  were	
  saved	
  and	
  verified	
  to	
  have	
  collected	
  the	
  vocalization	
  

data	
  correctly,	
  they	
  were	
  then	
  analyzed.	
  The	
  first	
  measure	
  that	
  was	
  analyzed	
  was	
  the	
  total	
  

Akhundzadeh    12  
time	
  spent	
  vocalizing.	
  To	
  do	
  this,	
  the	
  data	
  analyst	
  combed	
  through	
  the	
  vocalization	
  
recordings	
  (5	
  minutes	
  in	
  length)	
  on	
  the	
  computer	
  application,	
  Adobe	
  Audition.	
  The	
  analyst	
  
sought	
  to	
  delete	
  the	
  empty	
  space	
  in	
  the	
  vocalization	
  recording,	
  where	
  the	
  animal	
  did	
  not	
  
make	
  any	
  calls,	
  to	
  determine	
  total	
  amount	
  of	
  time	
  spent	
  vocalizing.	
  If	
  the	
  space	
  between	
  the	
  
calls	
  was	
  greater	
  than	
  2	
  milliseconds,	
  it	
  was	
  deleted	
  from	
  the	
  audio.	
  If	
  the	
  empty	
  space	
  
between	
  two	
  calls	
  was	
  less	
  than	
  2	
  milliseconds,	
  it	
  was	
  kept	
  and	
  that	
  time	
  was	
  counted	
  
towards	
  the	
  total	
  time	
  spent	
  vocalizing.	
  From	
  there,	
  once	
  all	
  of	
  the	
  empty/quiet	
  space	
  was	
  
removed,	
  the	
  length	
  of	
  the	
  audio	
  file	
  indicated	
  how	
  much	
  time	
  the	
  animal	
  spent	
  vocalizing	
  
in	
  seconds.	
  	
  
The	
  next	
  analyzation	
  step	
  was	
  to	
  identify	
  and	
  categorize	
  the	
  shapes	
  of	
  the	
  calls.	
  A	
  single	
  
experimenter	
  blind	
  to	
  the	
  condition	
  of	
  the	
  animals	
  went	
  through	
  each	
  call	
  manually,	
  
identified	
  the	
  shape	
  that	
  they	
  saw	
  best	
  fit,	
  and	
  manually	
  recorded	
  it.	
  A	
  few	
  categories	
  of	
  
calls	
  were	
  identified	
  from	
  a	
  previous	
  study.	
  They	
  are	
  as	
  follows,	
  from	
  Ey	
  et.	
  al,	
  2013	
  [20]:	
  
•

Short:  duration  shorter  than  5  milliseconds  and  frequency  range  ≤  6.25  kHz  

•

Simple:  duration  longer  than  5  milliseconds  and  frequency  range  ≤  6.25  kHz  
a. Contains  flat,  up,  down,  chevron  and  reverse  shapes  

•

Complex:  frequency  modulations  in  more  than  one  direction  and  frequency  range  >  
6.25  kHz,  or  inclusion  of  one  or  more  additional  frequency  components  but  no  
constraint  on  frequency  range  

•

One  Frequency  Jump:  inclusion  of  one  jump  in  frequency  without  time  gap  between  
the  consecutive  frequency  components  

•

Two  Frequency  Jump:  inclusion  of  two  jumps  in  frequency  without  time  gap  
between  the  consecutive  frequency  components  
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•

Noisy:  no  pure  tone  component  identifiable  

The  vocalization  calls  were  analyzed  one  by  one,  with  the  shapes  in  Figure  1  as  a  guideline.  
The  final  call  of  category  type  was  left  to  the  discretion  of  the  blinded  data  analyst.    
  

  
Figure  1.  Presentation  of  the  various  call  types,  with  spectrograms  of  examples  of  vocalizations  within  each  
call  type.  Image  taken  from  Heckman  et.  al,  2016  [21].    
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Results  
  

The  data  analysis  was  run  with  IBM  SPSS  Statistics,  a  computer  program,  using  an  

ANOVA  with  repeated  measures  to  determine  if  genotype  had  a  significant  effect  on  time  
spent  vocalizing.  The  results  showed  that  Genotype  had  no  significant  effect  on  total  time  
spent  vocalizing  overall  (p=  0.583).  These  results  can  be  seen  in  Figure  2.    
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Figure  2.  Effect  of  genotype  on  total  time  spent  vocalizing.  No  significant  results  were  found.    
  

Next  we  ran  an  ANOVA  test  on  the  different  call  types  of  the  mice,  but  no  significant  
effect  of  Genotype  on  call  type  was  found.  A  second  ANOVA  repeated  measures  test  was  run  
with  time  spent  vocalizing  as  a  covariant,  and  the  results  remained  the  same  –  no  
significant  effect  of  Genotype  on  call  type  category.  There  were  no  significant  between-‐
subject  or  within-‐subject  effects  of  Genotype  on  call  rates.  The  p-‐values  ranged  from  
p=0.180  for  the  call  type  chevron  to  p=0.953  for  the  call  type  short  –  again,  indicating  no  
significant  effect.  The  average  amount  of  calls  in  each  category  are  organized  by  Genotype  
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in  Figure  3.  Typically,  an  asterisk  sign  above  the  bars  on  the  graph  would  indicate  
significance.  In  the  case  of  this  data  set,  there  were  no  significant  results.    
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Figure  3.  Effect  of  genotype  on  Mouse  ultrasonic  vocalizations  using  the  ANOVA  test.  No  significant  effect  of  
genotype  on  call  type  was  observed.    
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Discussion  
  

The  lack  of  significant  effects  of  genotype  on  time  spent  vocalizing  and  the  shape  of  

call  types  is  interesting,  in  and  of  itself.  A  different  part  of  this  same  study,  analyzed  and  
performed  by  other  members  of  the  lab,  found  receptive  Genotype  differences  that  depend  
on  auditory  task  and  frequency.  Specifically,  USH2A  Het  mice  showed  auditory  deficits  on  
tasks  using  a  lower  frequency  range  (10-‐15kHz)  but  were  comparable  to  WT  on  tasks  
using  a  higher  frequency  range.  Furthermore,  the  USH2A  KO  mice  showed  auditory  deficits  
on  tasks  using  higher  frequency  range  (10-‐40kHz),  but  were  comparable  to  or  better  than  
WT  on  tasks  using  a  lower  frequency  range.  These  results  are  consistent  with  previous  in-‐
depth  studies  on  carriers  of  Usher  syndrome  type  2  and  USH2A  carriers  [14].    
  

The  insignificant  vocalization  data  presented  in  this  project,  in  conjunction  with  the  

findings  of  carrier  auditory  deficits  in  other  studies,  may  indicate  something  important.  
Although  receptive  differences  were  seen  between  WT,  Het  and  KO  mice,  there  were  no  
significant  vocal  production  differences  between  the  genotypes.  This  is  a  surprising  
discovery,  and  is  worth  taking  another  look  at.  Findings  suggest  the  subjects  were  able  to  
produce  vocalizations  normally,  despite  difficulties  hearing  these  sounds.    
  

There  were  several  limitations  of  the  data  collection  that  may  have  influenced  the  

lack  of  significant  results.  Each  subject  was  recorded  for  only  one  5-‐minute  trial.  Multiple  
trials  allow  for  consistency  and  reliability  in  results.  A  lack  of  several  trials  limits  
confidence  in  the  results.  The  lack  of  significant  findings  can  be  indicative  of  no  vocal  
production  differences  between  genotypes,  which  is  an  interesting  finding  that  warrants  
further  research,  or  it  could  be  a  potential  flaw  in  the  data  collection  process.  The  lack  of  
multiple  trials  does  not  allow  for  either  conclusion  to  be  made  confidently.  Furthermore,  
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there  were  only  35  subjects  total.  In  the  case  of  research  such  as  this,  more  subjects  are  
always  more  beneficial.  It  allows  for  the  examination  of  more  data,  and  greater  
representation  of  each  genotype  studied.  Another  limitation  of  the  data  is  the  lack  of  female  
subjects.  For  this  study,  only  male  subjects  were  studied.  In  the  world  of  research,  when  an  
entire  portion  of  the  population  is  left  out  of  the  study,  this  is  limiting  in  nature.  Including  
female  mice  in  the  study  could  have  allowed  for  us  to  determine  the  effect  of  Genotype  on  
call  types  by  sex,  which  could  have  provided  more  insight.  Lastly,  there  was  only  one  
experimenter  who  analyzed  the  data.  They  went  through  each  call  manually,  labeling  the  
call  type  structure  individually  and  tallying  up  the  total  time  spent  vocalizing.  While  there  
are  benefits  to  having  one  experimenter  analyze  the  data,  if  they  are  not  consistent  or  
categorize  the  calls  incorrectly,  this  can  affect  the  data.  The  experimenter  also  took  several  
months  to  analyze  the  data.  The  method  of  analyzing  could  have  differed  from  the  first  
subject  that  was  reviewed  (Subject  1)  to  the  last  one  (Subject  36).  All  of  the  above  are  
limitations  that  must  be  considered  when  interpreting  the  results,  since  they  may  have  
impacted  the  lack  of  significance.    
  

Future  Directions  
  

There  are  many  further  inquiries  that  can  be  made  into  the  USH2A  gene  and  Usher  

syndrome  type  2.  First  and  foremost,  it  would  be  important  to  replicate  this  study.  As  
mentioned  previously,  the  lack  of  significant  differences  between  genotypes  in  vocal  
production  may  be  an  important  discovery.  Unfortunately,  because  each  subject  only  had  
one  trial,  the  results  are  not  entirely  dependable.  An  exact  replication  of  this  study  with  a  
new  set  of  subjects,  and  a  different  experimenter  analyzing  the  data  will  provide  insight  on  
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whether  or  not  these  results  are  reliable  and  accurate.  Furthermore,  histological  analysis  
should  be  performed  to  further  analyze  genotype  effects.  An  anatomical  review  may  
provide  surprising  or  interesting  findings,  which  will  not  be  known  until  it  is  done  and  
analyzed.  On  the  question  of  carriers,  further  behavioral  testing  should  be  performed  to  see  
if  there  are  any  other  deficits  that  they  may  exhibit  in  hearing  or  vision  loss.  This  is  a  new  
area  of  research  that  studies  are  beginning  to  look  into  –  it  is  definitely  a  topic  worth  
pursuing  further.    
  

One  important  way  to  take  this  study  one  step  further  is  to  study  vocal  production  

in  the  human  patient,  carrier  and  non-‐carrier  population.  A  study  that  can  both  show  that  
carriers  have  varied  hearing  loss  that  is  not  as  severe  as  someone  who  is  diagnosed  with  
Usher  syndrome,  and  that  there  are  no  vocal  production  differences  across  patients,  
carriers  and  non-‐carriers  would  be  very  intriguing.  This  idea  is  worth  taking  a  further  look  
at.  Lastly,  it  is  very  important  to  remember  why  all  of  this  research  is  being  done.  The  more  
that  is  understood  about  Usher  syndrome,  the  closer  and  closer  the  scientific  community  
comes  to  finding  a  more  definitive  method  of  diagnosis,  better  treatment  interventions,  and  
hopefully  one  day  soon,  a  cure.  Ultimately,  all  research  is  done  to  better  the  outcomes  of  
human  beings  who  are  afflicted.  This  research,  while  innovating  and  exciting  in  and  of  
itself,  is  simply  one  cog  in  a  machine  focused  on  curing  the  enigma  that  is  Usher  syndrome.    
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